Davita Inc vs Howmet Aerospace Inc — how do they compare? Davita Inc trades at $178.89 (market cap $11.29B), while Howmet Aerospace Inc trades at $222.89 (market cap $88.76B). The key difference: Howmet Aerospace Inc is far larger — about 7.9× Davita Inc's market cap, and Howmet Aerospace Inc pays a 0.25% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Howmet Aerospace Inc for 35 Days on average.
| DVA | HWM | |
|---|---|---|
Market Cap | $11.29B | $88.76B |
Volume | 582,204 | 2,648,516 |
Sector | Health | Industrials |
52-Week High | $240.96 | $292.65 |
52-Week Low | $103.87 | $184.09 |
Typical Hold Time | 113 Days | 35 Days |
Enterprise Value | $24.01B | $92.86B |
Dividend Yield | — | 0.25% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, with a bearish technical signal and neutral oscillators. The company shows strong earnings beats in recent quarters with Q2 2026 EPS of $4.02 beating expectations of $3.88. Revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026, though net margins have fluctuated. Recent partnership expansion with Humana for value-based kidney care represents significant business development.
DVA presents a mixed outlook with 43% analyst buy ratings and a $235.67 price target suggesting 33% upside. However, high debt levels (65.55% debt-to-asset ratio) and regulatory risks in healthcare weigh on fundamentals. The stock's current valuation at P/E 15 and P/S 0.88 appears reasonable relative to earnings growth potential, making it attractive for value investors despite near-term bearish technicals.
Howmet Aerospace (HWM) trades at $222.7, down 3.84% today, with a bearish technical signal but strong fundamentals including 20.52% net income margin and consistent earnings beats. The stock is supported by robust cash flow and a dominant position in aerospace components, with upcoming Q3 2026 results on October 29, 2026, per PRNewsWire. Analyst consensus is overwhelmingly bullish with an 84% buy rating and a $328.10 price target, indicating significant upside potential from current levels.
The outlook for HWM remains positive driven by defense and commercial aerospace demand, though risks include supply-chain pressures and market volatility. The stock's high valuation multiples like a P/E of 47.97 require sustained growth, but institutional interest and dividend payments reinforce confidence. Investors should weigh the strong growth trajectory against macroeconomic headwinds affecting the sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →